Shin Nippon Biomedical Laboratories (FRA:YB3) FFO


FRA:YB3 Shin Nippon Biomedical Laboratories Ltd FRA:YB3
77 GF Score
Price €6.10
GF Value €9.40
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

FRA:YB3
77GF Score
Shin Nippon Biomedical Laboratories Ltd FRA:YB3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shin Nippon Biomedical Laboratories (FRA:YB3) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of €6.10 is trading 35.1% below its estimated GF Value™ of €9.40.

Key valuation signals for FRA:YB3:

  • FFO:
  • GF Value™: €9.40 vs. price of €6.10 (35.1% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:YB3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
77GF Score

Get the complete analysis for FRA:YB3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price
€9.40
GF Value